Stock WCGC WCG CLINICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company WCG Clinical, Inc.

Equities

WCGC

US92941R1095

Biotechnology & Medical Research

Delayed Nasdaq
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for WCG Clinical, Inc. -.--% -.--%
2021 WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans RE
2021 WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans RE

Business Summary

WCG Clinical Holdings Inc is a United States-based company. The Company is a provider of clinical trial solutions. It is focused on providing solutions that are designed to improve clinical research. Its solutions help biopharmaceutical companies, contract research organizations, and institutions for delivery of new treatments and therapies to patients. It is organized into two segments: Ethical Review (ER) segment and Clinical Trial Solutions segment. The ER segment provides technology-enabled services that ensure clinical trials respect the rights and protect the welfare of patient participants. ER segment also provides a hosted software application to its clients. Clinical Trial Solutions (CTS) segment provides technology-enabled solutions that support the conduct of effective clinical trials, including study planning and site optimization, patient engagement, and scientific and regulatory review.

Managers

Managers TitleAgeSince
Srivastava Sam CEO
 Chief Executive Officer - -
Nicholas Slack PSD
 President 41 12-06-30
Ian Neilson CTO
 Chief Tech/Sci/R&D Officer - 17-12-31
Lindsay McNair CTO
 Chief Tech/Sci/R&D Officer - -
David Forster CMP
 Compliance Officer - -
Lisa Calicchio HRO
 Human Resources Officer - -
Marco Capasso LAW
 General Counsel - -
Barbara J. Shander LAW
 General Counsel 54 21-03-31
Stephen M. McLean TRE
 Treasurer 41 12-12-31

Members of the board

Members of the board TitleAgeSince
John Baumer BRD
 Director/Board Member 56 18-12-31
Eugene Gorbach BRD
 Director/Board Member 47 11-12-31
Stephen M. McLean BRD
 Director/Board Member 66 11-12-31
James Rothman BRD
 Director/Board Member 74 12-01-31
Richard Pilnik BRD
 Director/Board Member 67 21-03-31
Christina Armstrong BRD
 Director/Board Member - 11-12-31
Kavita Patel BRD
 Director/Board Member 50 20-10-31
Henrik Kjaer Hansen BRD
 Director/Board Member 48 19-12-31
Peter Zippelius BRD
 Director/Board Member 45 18-12-31
Charles D. Kennedy BRD
 Director/Board Member - -

Company contact information

WCG Clinical, Inc.

1019 39th Avenue SE

98374, Puyallup

+

http://www.wcgclinical.com
address WCG Clinical, Inc.(WCGC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
WCG CLINICAL, INC. Stock WCG Clinical, Inc.
-.--% 6.07B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. WCGC Stock
  4. Company WCG Clinical, Inc.